Clinical Trial Update: A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

View source ↗

Summary

A completed national multicenter observational study in Greece assessing patient characteristics, treatment patterns, and management of hyperkalemia in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure
• Hyperkalemia

Drugs mentioned

• Lokelma (sodium zirconium cyclosilicate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalaemia | Status: COMPLETED